Methicillin-resistant Staphylococcus aureus (MRSA) causes biofilm-related medical device
infections. Phage-antibiotic combinations offer potential therapy due to proven in vitro …

Bacterial biofilms are difficult to eradicate and can complicate many infections by forming on
tissues and medical devices. Phage+ antibiotic combinations (PAC) may be more active on …

Phage therapy has gained attention due to the spread of antibiotic-resistant bacteria and
narrow pipeline of novel antibiotics. Phage cocktails are hypothesized to slow the overall …

The inability to effectively treat biofilm-related infections is a major clinical challenge. This
has been attributed to the heightened antibiotic tolerance conferred to bacterial cells …

Multidrug-resistant (MDR) Enterococcus faecium is a challenging nosocomial pathogen
known to colonize medical device surfaces and form biofilms. Bacterio (phages) may …

The high infection and mortality rate of methicillin-resistant Staphylococcus aureus (MRSA)
necessitates the urgent development of new treatment strategies. Bacteriophages (phages) …

Phage therapy is drawing more interest as antibiotic resistance becomes an ever more
serious threat to public health. Bacterial biofilms represent a major obstacle in the fight …

Staphylococcus aureus´ biofilm-forming ability and rapid resistance development pose a
significant challenge to successful treatment, particularly in postoperative complications …

Introduction: The emergence of antibiotic resistance is a significant challenge in the
treatment of bacterial infections, particularly in patients in the intensive care unit (ICU) …

Methicillin-resistant Staphylococcus aureus (MRSA) infections are some of the most
common antibiotic-resistant infections, often exacerbated by the formation of biofilms. Here …